Literature DB >> 18929414

Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15.

Aristo Vojdani1, Elizabeth Mumper, Doreen Granpeesheh, Lynne Mielke, David Traver, Kenneth Bock, Karima Hirani, James Neubrander, Kurt N Woeller, Nancy O'Hara, Anju Usman, Cindy Schneider, Frank Hebroni, Joshua Berookhim, Jaquelyn McCandless.   

Abstract

Although many articles have reported immune abnormalities in autism, NK cell activity has only been examined in one study of 31 patients, of whom 12 were found to have reduced NK activity. The mechanism behind this low NK cell activity was not explored. For this reason, we explored the measurement of NK cell activity in 1027 blood samples from autistic children obtained from ten clinics and compared the results to 113 healthy controls. This counting of NK cells and the measurement of their lytic activity enabled us to express the NK cell activity/100 cells. At the cutoff of 15-50 LU we found that NK cell activity was low in 41-81% of the patients from the different clinics. This NK cell activity below 15 LU was found in only 8% of healthy subjects (p<0.001). Low NK cell activity in both groups did not correlate with percentage and absolute number of CD16(+)/CD56(+) cells. When the NK cytotoxic activity was expressed based on activity/100 CD16(+)/CD56(+) cells, several patients who had displayed NK cell activity below 15 LU exhibited normal NK cell activity. Overall, after this correction factor, 45% of the children with autism still exhibited low NK cell activity, correlating with the intracellular level of glutathione. Finally, we cultured lymphocytes of patients with low or high NK cell activity/cell with or without glutathione, IL-2 and IL-15. The induction of NK cell activity by IL-2, IL-15 and glutathione was more pronounced in a subgroup with very low NK cell activity. We conclude that that 45% of a subgroup of children with autism suffers from low NK cell activity, and that low intracellular levels of glutathione, IL-2 and IL-15 may be responsible.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18929414     DOI: 10.1016/j.jneuroim.2008.09.005

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  36 in total

Review 1.  The role of immune dysfunction in the pathophysiology of autism.

Authors:  Charity Onore; Milo Careaga; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2011-08-28       Impact factor: 7.217

Review 2.  Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

Authors:  Dominika Gładysz; Amanda Krzywdzińska; Kamil K Hozyasz
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

3.  Determination of neuroinflammatory biomarkers in autistic and neurotypical Saudi children.

Authors:  Najat O Hamed; Mohamed A Osman; Abdalla O Elkhawad; Geir Bjørklund; Hanan Qasem; Naima Zayed; Afaf El-Ansary
Journal:  Metab Brain Dis       Date:  2019-05-30       Impact factor: 3.584

4.  Randomized controlled trial of oral glutathione supplementation on body stores of glutathione.

Authors:  John P Richie; Sailendra Nichenametla; Wanda Neidig; Ana Calcagnotto; Jeremy S Haley; Todd D Schell; Joshua E Muscat
Journal:  Eur J Nutr       Date:  2014-05-05       Impact factor: 5.614

5.  Levels of soluble platelet endothelial cell adhesion molecule-1 and P-selectin are decreased in children with autism spectrum disorder.

Authors:  Charity E Onore; Christine Wu Nordahl; Gregory S Young; Judy A Van de Water; Sally J Rogers; Paul Ashwood
Journal:  Biol Psychiatry       Date:  2012-06-19       Impact factor: 13.382

6.  Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

Authors:  Mahtab Asadabadi; Mohammad-Reza Mohammadi; Ahmad Ghanizadeh; Amirhossein Modabbernia; Mandana Ashrafi; Elmira Hassanzadeh; Saeedeh Forghani; Shahin Akhondzadeh
Journal:  Psychopharmacology (Berl)       Date:  2012-07-11       Impact factor: 4.530

Review 7.  Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis.

Authors:  A Masi; D S Quintana; N Glozier; A R Lloyd; I B Hickie; A J Guastella
Journal:  Mol Psychiatry       Date:  2014-06-17       Impact factor: 15.992

8.  Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function.

Authors:  R Sinha; I Sinha; A Calcagnotto; N Trushin; J S Haley; T D Schell; J P Richie
Journal:  Eur J Clin Nutr       Date:  2017-08-30       Impact factor: 4.016

9.  The modulation of immunological activities in human NK cells by extracts of ginkgo.

Authors:  Hiroki Matsushima; Kanehisa Morimoto
Journal:  Environ Health Prev Med       Date:  2009-09-12       Impact factor: 3.674

Review 10.  Autoimmunity in autism.

Authors:  Amanda M Enstrom; Judy A Van de Water; Paul Ashwood
Journal:  Curr Opin Investig Drugs       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.